.png){kind=icon}
.png){kind=icon}
Return
Forced vital capacity in pulmonary exacerbations of cystic fibrosis
.png){kind=icon}
PRE
AI
O
S
D
N
K
B
P
C
DOI：10.1016/j.jcf.2026.07.010.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Pulmonary exacerbations produce heterogeneous changes in FVC. • Larger FVC deficits are associated with increased inflammatory burden. • Large FVC deficits identify patients at higher risk of recurrence. • Residual FEV1 deficit predicts recurrence more robustly than FVC. • FVC offers no clear advantage over FEV1 as a clinical trial endpoint.
Journal
IF:
6
Papers:
2.9K
Citations:
7.3K
Organization
Cited Papers